Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions

Alvise Sernicola, Irene Russo, Micol Silic-Benussi, Vincenzo Ciminale, Mauro Alaibac

Research output: Contribution to journalReview articlepeer-review

Abstract

Introduction: The cutaneous lymphocyte antigen interacts with E-selectin on endothelial cells and is expressed on 15% of circulating T-cells. Skin-homing T-cells express the cutaneous lymphocyte antigen and play a role in local cutaneous immunity in inflammatory reactions and neoplastic conditions.Areas covered: Lymphocyte extravasation is the essential para-physiological mechanism enabling immune surveillance of tissues for tumors as well as effector cell recruitment to inflammatory sites.The authors focused on skin inflammatory disorders, on cutaneous lymphoproliferative disease, and on other skin malignancies.Expert opinion: Interfering with leukocyte extravasation has been regarded as an attractive strategy in skin disorders, in the past for inflammatory conditions and more recently for cutaneous T-cell lymphomas. Therapeutic blocking of skin-homing interactions has been attempted in psoriasis and atopic dermatitis and has been achieved in the treatment of cutaneous T-cell lymphomas. Cutaneous lymphocyte antigen is a potential molecular target for both systemic and skin-directed therapy for cutaneous T-cell lymphomas.

Original languageEnglish
Pages (from-to)275-282
Number of pages8
JournalExpert Opinion on Biological Therapy
Volume20
Issue number3
DOIs
Publication statusPublished - Mar 2020

Keywords

  • Antibodies, Monoclonal, Humanized/therapeutic use
  • Humans
  • Lymphoma, T-Cell, Cutaneous/metabolism
  • Lymphoproliferative Disorders/drug therapy
  • Oligosaccharides/antagonists & inhibitors
  • Sialyl Lewis X Antigen/analogs & derivatives
  • Skin Diseases/drug therapy
  • Skin Neoplasms/drug therapy
  • T-Lymphocytes/immunology
  • Tumor Microenvironment

Fingerprint Dive into the research topics of 'Targeting the cutaneous lymphocyte antigen (CLA) in inflammatory and neoplastic skin conditions'. Together they form a unique fingerprint.

Cite this